Balloon-expandable prostheses for transcatheter aortic valve replacement

Progress in Cardiovascular Diseases

Volumn 56, Issue 6, 2014, Pages 583-595

  Ribeiro, Henrique Barbosa ^a   Urena, Marina ^a   Allende, Ricardo ^a   Amat Santos, Ignacio J ^a   Rodés Cabau, Josep ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Aortic stenosis; Balloon expandable; Transcatheter aortic Valve replacement; Transcatheter heart valve

Indexed keywords

AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; BALLOON EXPANDABLE PROSTHESIS; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CORONARY ARTERY OBSTRUCTION; DEVICE SAFETY; DISEASE SEVERITY; EMBOLISM; HEART HEMODYNAMICS; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VALVE BIOPROSTHESIS; HEART VENTRICLE CONDUCTION; HIGH RISK PATIENT; HUMAN; MEDICAL DEVICE COMPLICATION; MORTALITY; MULTICENTER STUDY (TOPIC); PROSTHESIS; PROSTHETIC VALVE MALPOSITIONING; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

AORTIC STENOSIS; BALLOON-EXPANDABLE; TRANSCATHETER AORTIC VALVE REPLACEMENT; TRANSCATHETER HEART VALVE;

AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; PROSTHESIS DESIGN; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84900014206     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2014.02.001     Document Type: Article

References (86)

1. Andersen H.R., Knudsen L.L., Hasenkam J.M. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992, 13:704-708.
2. Bonhoeffer P., Boudjemline Y., Saliba Z., et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000, 356:1403-1405.
3. Cribier A., Eltchaninoff H., Bash A., et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002, 106:3006-3008.
4. Rodes-Cabau J. Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol 2012, 9:15-29.
5. Cribier A., Eltchaninoff H., Tron C., et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004, 43:698-703.
6. Clavel M.A., Dumont E., Pibarot P., et al. Severe valvular regurgitation and late prosthesis embolization after percutaneous aortic valve implantation. Ann Thorac Surg 2009, 87:618-621.
7. Makkar R.R., Jilaihawi H., Chakravarty T., et al. Determinants and Outcomes of Acute Transcatheter Valve-in-Valve Therapy or Embolization: A Study of Multiple Valve Implants in the U.S. PARTNER Trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve). J Am Coll Cardiol 2013, 62:418-430.
8. Binder R.K., Rodes-Cabau J., Wood D.A., et al. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv 2013, 6:293-300.
9. Ribeiro H.B., Doyle D., Nombela-Franco L., et al. Transapical Implantation of the SAPIEN 3 Valve. J Card Surg 2013, 28:506-509.
10. Webb J.G., Chandavimol M., Thompson C.R., et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006, 113:842-850.
11. Ye J., Cheung A., Lichtenstein S.V., et al. Transapical aortic valve implantation in humans. J Thorac Cardiovasc Surg 2006, 131:1194-1196.
12. Rodes-Cabau J., Dumont E., De LaRochelliere R., et al. Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am J Cardiol 2008, 102:1240-1246.
13. Hayashida K., Lefevre T., Chevalier B., et al. True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications. JACC Cardiovasc Interv 2012, 5:207-214.
14. Toggweiler S., Gurvitch R., Leipsic J., et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol 2012, 59:113-118.
15. Lichtenstein S.V., Cheung A., Ye J., et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006, 114:591-596.
16. Thomas M., Schymik G., Walther T., et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011, 124:425-433.
17. Rodes-Cabau J., Webb J.G., Cheung A., et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010, 55:1080-1090.
18. Wendler O. The Multicenter SOURCE XT TAVR Registry 2012, EuroPCR, Paris, France.
19. Bagur R., Rodes-Cabau J., Doyle D., et al. Usefulness of TEE as the primary imaging technique to guide transcatheter transapical aortic valve implantation. JACC Cardiovasc Imaging 2011, 4:115-124.
20. Rodes-Cabau J., Gutierrez M., Bagur R., et al. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol 2011, 57:1988-1999.
21. Dumont E., Rodes-Cabau J., De LaRochelliere R., Lemieux J., Villeneuve J., Doyle D. Rapid pacing technique for preventing ventricular tears during transapical aortic valve replacement. J Card Surg 2009, 24:295-298.
22. Amat-Santos I.J., Dumont E., Villeneuve J., et al. Effect of thoracic epidural analgesia on clinical outcomes following transapical transcatheter aortic valve implantation. Heart 2012, 98:1583-1590.
23. Petronio A.S., De Carlo M., Bedogni F., et al. 2-Year Results of CoreValve Implantation Through the Subclavian Access: A Propensity-Matched Comparison With the Femoral Access. J Am Coll Cardiol 2012, 60:502-507.
24. De Robertis F., Asgar A., Davies S., et al. The left axillary artery-a new approach for transcatheter aortic valve implantation. Eur J Cardiothorac Surg 2009, 36:807-812.
25. Ruggieri V.G., Bedossa M., Verhoye J.P. Urgent trans-axillary valve-in-valve procedure using the Edwards 16F expandable introducer. Catheter Cardiovasc Interv 2012, 10.1002/ccd.24771.
26. Sharp A.S., Michev I., Colombo A. First trans-axillary implantation of Edwards Sapien valve to treat an incompetent aortic bioprosthesis. Catheter Cardiovasc Interv 2010, 75:507-510.
27. Ferrari E., Berdajs D., Tozzi P., Pretre R. Transaortic transcatheter aortic valve replacement with the Sapien valve and the first generations of Ascendra. Eur J Cardiothorac Surg 2014, 45:188-190.
28. Bapat V., Khawaja M.Z., Attia R., et al. Transaortic Transcatheter Aortic valve implantation using Edwards Sapien valve: a novel approach. Catheter Cardiovasc Interv 2012, 79:733-740.
29. Hayashida K., Romano M., Lefevre T., et al. The transaortic approach for transcatheter aortic valve implantation: a valid alternative to the transapical access in patients with no peripheral vascular option. A single center experience. Eur J Cardiothorac Surg 2013, 44:692-700.
30. Etienne P.Y., Papadatos S., Mailleux P., et al. Exclusive percutaneous approach for surgical transaortic transcatheter valve replacement. Ann Thorac Surg 2013, 95:1812-1814.
31. Hahn R.T. Use of imaging for procedural guidance during transcatheter aortic valve replacement. Curr Opin Cardiol 2013, 28:512-517.
32. Durand E., Borz B., Godin M., et al. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc Interv 2012, 5:461-467.
33. Pasic M., Unbehaun A., Dreysse S., et al. Transapical aortic valve implantation in 175 consecutive patients: excellent outcome in very high-risk patients. J Am Coll Cardiol 2010, 56:813-820.
34. Mok M., Dumont E., Doyle D., Rodes-Cabau J. Transcatheter aortic valve implantation using the slow balloon inflation technique: making balloon-expandable valves partially repositionable. J Card Surg 2012, 27:546-548.
35. Bosmans J.M., Kefer J., De Bruyne B., et al. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg 2011, 12:762-767.
36. Eltchaninoff H., Prat A., Gilard M., et al. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 2011, 32:191-197.
37. Gilard M., Eltchaninoff H., Iung B., et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012, 366:1705-1715.
38. Leon M.B., Smith C.R., Mack M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010, 363:1597-1607.
39. Moat N.E., Ludman P., de Belder M.A., et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011, 58:2130-2138.
40. Smith C.R., Leon M.B., Mack M.J., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011, 364:2187-2198.
41. Walther T., Kasimir M.T., Doss M., et al. One-year interim follow-up results of the TRAVERCE trial: the initial feasibility study for trans-apical aortic-valve implantation. Eur J Cardiothorac Surg 2011, 39:532-537.
42. Zahn R., Gerckens U., Grube E., et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 2011, 32:198-204.
43. Leon M.B. A Randomized Evaluation of the SAPIEN XT Transcatheter Valve System in Patients with Aortic Stenosis Who Are Not Candidates for Surgery: PARTNER II, Inoperable Cohort 2013, ACC, San Francisco, USA.
44. Lefevre T., Kappetein A.P., Wolner E., et al. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 2011, 32:148-157.
45. Khatri P.J., Webb J.G., Rodes-Cabau J., et al. Adverse Effects Associated With Transcatheter Aortic Valve Implantation: A Meta-analysis of Contemporary Studies. Ann Intern Med 2013, 158:35-46.
46. Leon M.B., Piazza N., Nikolsky E., et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011, 57:253-269.
47. Kappetein A.P., Head S.J., Genereux P., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document. J Am Coll Cardiol 2012, 60:1438-1454.
48. Watanabe Y., Hayashida K., Lefevre T., et al. Transcatheter aortic valve implantation in patients of small body size. Catheter Cardiovasc Interv 2013, 10.1002/ccd.24970.
49. Hayashida K., Lefevre T., Chevalier B., et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv 2011, 4:851-858.
50. Genereux P., Kodali S., Leon M.B., et al. Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation. JACC Cardiovasc Interv 2011, 4:861-867.
51. van der Boon R.M., Nuis R.J., Van Mieghem N.M., et al. New conduction abnormalities after TAVI-frequency and causes. Nat Rev Cardiol 2012, 9:454-463.
52. Urena M., Mok M., Serra V., et al. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol 2012, 60:1743-1752.
53. Bagur R., Rodes-Cabau J., Gurvitch R., et al. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. JACC Cardiovasc Interv 2012, 5:540-551.
54. Eggebrecht H., Schmermund A., Voigtlander T., Kahlert P., Erbel R., Mehta R.H. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 2012, 8:129-138.
55. Nombela-Franco L., Webb J.G., de Jaegere P.P., et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation 2012, 126:3041-3053.
56. Rodes-Cabau J., Dumont E., Boone R.H., et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol 2011, 57:18-28.
57. Rodes-Cabau J., Dauerman H.L., Cohen M.G., et al. Antithrombotic Treatment in Transcatheter Aortic Valve Implantation: Insights for Cerebrovascular and Bleeding Events. J Am Coll Cardiol 2013, 62:2349-2359.
58. Ribeiro H.B., Nombela-Franco L., Urena M., et al. Coronary obstruction following transcatheter aortic valve implantation: a systematic review. JACC Cardiovasc Interv 2013, 6:452-461.
59. Ribeiro H.B., Webb J., Makkar R., et al. Predictive Factors, Management and Clinical Outcomes of Coronary Obstruction Following Transcatheter Aortic Valve Implantation: Insights from a Large Multicenter Registry. J Am Coll Cardiol 2013, 62:1552-1562.
60. Kodali S.K., Williams M.R., Smith C.R., et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012, 366:1686-1695.
61. Makkar R.R., Fontana G.P., Jilaihawi H., et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012, 366:1696-1704.
62. Kapadia S.R. Three-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in "Inoperable" Patients With Severe Aortic Stenosis: The PARTNER Trial 2012, TCT, Miami, USA.
63. Thourani V.H. Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in High- Risk Patients with Severe Aortic Stenosis 2013, ACC, San Francisco, USA.
64. Reynolds M.R., Magnuson E.A., Wang K., et al. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol 2012, 60:548-558.
65. Reynolds M.R., Magnuson E.A., Lei Y., et al. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation 2011, 124:1964-1972.
66. Rodes-Cabau J., Webb J.G., Cheung A., et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol 2012, 60:1864-1875.
67. Toggweiler S., Humphries K.H., Lee M., et al. 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol 2013, 61:413-419.
68. Piazza N., Grube E., Gerckens U., et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008, 4:242-249.
69. Tamburino C., Capodanno D., Ramondo A., et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011, 123:299-308.
70. Walther T., Falk V., Kempfert J., et al. Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur J Cardiothorac Surg 2008, 33:983-988.
71. Clavel M.A., Webb J.G., Pibarot P., et al. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol 2009, 53:1883-1891.
72. Hahn R.T., Pibarot P., Stewart W.J., et al. Comparison of Transcatheter and Surgical Aortic Valve Replacement in Severe Aortic Stenosis: A Longitudinal Study of Echocardiography Parameters in Cohort A of the PARTNER Trial (Placement of Aortic Transcatheter Valves). J Am Coll Cardiol 2013, 61:2514-2521.
73. Lerakis S., Hayek S.S., Douglas P.S. Paravalvular aortic leak after transcatheter aortic valve replacement: current knowledge. Circulation 2013, 127:397-407.
74. Athappan G., Patvardhan E., Tuzcu E.M., et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol 2013, 61:1585-1595.
75. Detaint D., Lepage L., Himbert D., et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc Interv 2009, 2:821-827.
76. Ng A.C., Delgado V., van der Kley F., et al. Comparison of aortic root dimensions and geometries before and after transcatheter aortic valve implantation by 2- and 3-dimensional transesophageal echocardiography and multislice computed tomography. Circ Cardiovasc Imaging 2010, 3:94-102.
77. Messika-Zeitoun D., Serfaty J.M., Brochet E., et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol 2010, 55:186-194.
78. Jilaihawi H., Kashif M., Fontana G., et al. Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol 2012, 59:1275-1286.
79. Binder R.K., Webb J.G., Willson A.B., et al. The impact of integration of a multidetector computed tomography annulus area sizing algorithm on outcomes of transcatheter aortic valve replacement: a prospective, multicenter, controlled trial. J Am Coll Cardiol 2013, 62:431-438.
80. Nombela-Franco L., Ruel M., Radhakrishnan S., et al. Comparison of hemodynamic performance of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis. Am J Cardiol 2013, 111:1026-1033.
81. Watanabe Y., Hayashida K., Yamamoto M., et al. Transfemoral Aortic Valve Implantation in Patients With an Annulus Dimension Suitable for Either the Edwards Valve or the CoreValve. Am J Cardiol 2013, 112:707-713.
82. Latib A., Messika-Zeitoun D., Maisano F., et al. Reversible Edwards Sapien XT dysfunction due to prosthesis thrombosis presenting as early structural deterioration. J Am Coll Cardiol 2013, 61:787-789.
83. Cota L., Stabile E., Agrusta M., et al. Bioprostheses "thrombosis" after transcatheter aortic valve replacement. J Am Coll Cardiol 2013, 61:789-791.
84. Gaia D.F., Palma J.H., Souza J.A., et al. Off-pump transapical balloon-expandable aortic valve endoprosthesis implantation. Rev Bras Cir Cardiovasc 2009, 24:233-238.
85. Gaia D.F., Palma J.H., Ferreira C.B., et al. Transcatheter aortic valve implantation: results of the current development and implantation of a new Brazilian prosthesis. Rev Bras Cir Cardiovasc 2011, 26:338-347.
86. Urena P., Valdez I., Almanzar R., et al. 160-Day results of first human transcatheter aortic valve implntation of the Colibri Heart Valve, a pre-mounted, pre-packaged, low profile valve in a 14 french delivery system 2013, EuroPCR, Paris, France.